Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin or cannabidiol nanoemulsion eye drops for dry eye symptoms in Sjögren syndrome
RBR-7p43fkcPhase 2Recruiting
- Sponsor
- Faculdade de Medicina de Ribeirão Preto
- Start
- Mar 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in dry eye syndrome (DED) and Sjögren's syndrome comparing Insulin nanoemulsion eye drops, Cannabidiol nanoemulsion eye drops and Placebo eye drops (3 arms). Primary endpoints: Safety of insulin nanoemulsion eye drops, Safety of cannabidiol nanoemulsion eye drops and 1 more. Started Mar 2023; status: recruiting.
02
Drugs
human insulincannabidiol
03
Conditions
dry eye syndrome (DED)Sjögren's syndrome
Beyond the preview
Go deeper on RBR-7p43fkc.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7p43fkc.